In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated ...

The three price benefit managers jointly administer 80% of all prescriptions in the U.S., the FTC said in the lawsuit.

The agency alleges CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in ...

The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

CVS Health Corp. closed $24.83 short of its 52-week high ($83.25), which the company reached on January 8th.

We recently compiled a list of the 10 Best Fortune 500 Stocks To Buy Now. In this article, we are going to take a look at ...

The US Federal Trade Commission sued units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. on Friday, accusing ...

CVS Health Corp (CVS) stock saw a modest uptick, ending the day at $58.42 which represents a slight increase of $0.59 or 1.02% from the prior close of $57.83. The stock opened at $57.88 and touched a ...

On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...

Investing.com - CVS Health Corp (NYSE: CVS) reported second quarter EPS of $1.83, $0.10 better than the analyst estimate of $1.73. Revenue for the quarter came in at ...